Literature DB >> 9193777

AIDS-related extrapulmonary Pneumocystis carinii infection presenting as a solitary rectal ulcer.

E M Yoshida1, D Filipenko, P Phillips, J S Montaner, J S Whittaker.   

Abstract

Extrapulmonary infection with Pneumocystis carinii, although uncommon, is increasingly recognized. Use of aerosolized pentamidine versus a systemic medication is thought to be a contributing factor due to the low concentrations of drug that are incapable of suppressing systemic infection. Infection with P carinii has been reported in every organ system including the gastrointestinal system. A 28-year-old acquired immunodeficiency syndrome patient receiving prophylaxis with aerosolized pentamidine who presented with a solitary rectal ulcer is reported. Initial biopsy was characteristic of extrapulmonary P carinii infection, with numerous organisms present. Occasional cytomegalovirus inclusion bodies were noted which may have been a copathogen but which were not treated. Treatment with intravenous pentamidine resulted in documented eradication of P carinii and complete resolution of the ulcer. Although lower gastrointestinal pneumocystosis has been described without ulceration, this is the first description of rectal ulceration presenting as the initial manifestation of extrapulmonary pneumocystosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9193777     DOI: 10.1155/1996/870701

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  2 in total

1.  PCR diagnosis of Pneumocystis carinii on sputum and bronchoalveolar lavage samples in immuno-compromised patients.

Authors:  Somchai Pinlaor; Piroon Mootsikapun; Porntip Pinlaor; Anakapong Phunmanee; Vichit Pipitgool; Paiboon Sithithaworn; Worawan Chumpia; Jiraporn Sithithaworn
Journal:  Parasitol Res       Date:  2004-09-01       Impact factor: 2.289

2.  Extra-pulmonary Pneumocystis jiroveci infection: a case report.

Authors:  Mehrdad Bakhshayesh Karam; Leila Mosadegh
Journal:  Braz J Infect Dis       Date:  2014-07-19       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.